Development of a patient journey map for people living with Parkinson’s disease
Objective: Develop a Motor Fluctuations Patient Journey Map (MFPJM) for people with Parkinson’s disease (PwP) to describe the holistic experience from pre-diagnosis through long-term treatment,…Prodromal stage early biomarkers in Parkinson’s disease and parkinsonism in Uzbek nationality
Objective: Evaluation of prodromal stage biomarkers in Parkinson's disease and their role in disease progression Background: From a pathophysiological point of view, PD is characterized…A comparison of national data on Parkinson’s disease mortality between the USA and UK
Objective: To evaluate recent mortality trends in Parkinson’s Disease (PD) between the United States of America (USA) and the United Kingdom (UK) per national healthcare…Detection of freezing of gait in people with Parkinson’s disease using novel deep learning approaches.
Objective: To detect freezing of gait (FOG) in people with Parksinson’s disease using three novel deep learning approaches. Background: FOG is one of the most…Improvements in Parkinson’s disease motor complications after treatment with opicapone: results from the OPTI-ON study
Objective: To describe motor complications as measured by the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part IV in participants from the Opicapone Treatment…Recommendations to tackle under-recognition and under-treatment of sialorrhea in Parkinson’s Disease: Is it time for a paradigm shift?
Objective: To leverage patient survey data and expert opinion to develop recommendations for managing sialorrhea in patients with Parkinson’s disease (PD). Background: Sialorrhea, or drooling,…Long-term evolution of advanced Parkinson’s disease burden: second interim results from the international PROSPECT observational study
Objective: To evaluate the long-term evolution of clinical and economic outcomes and treatment patterns of patients with advanced Parkinson’s disease (PD) who have symptoms that…Association Between Anticholinergic Burden, MCI, and Cholinergic Denervation
Objective: To characterize the relationship between anticholinergic burden (ACB), mild cognitive impairment (MCI), and its underlying cholinergic pathology. Background: MCI is a common phenomenon in…Agreement between Parkinson disease Home Diary and observer assessments before and after structured patient training
Objective: The study aim was to investigate the effect of structured training concerning motor fluctuations on the agreement between observer and HD ratings and daily…Angiotensin-converting enzyme inhibitors prevent pneumonia in patients with Parkinson’s disease
Objective: This study aimed to evaluate the effects of angiotensin-converting enzyme inhibitors (ACEi) on the prevalence of pneumonia in patients with Parkinson’s disease (PD). Background:…
- « Previous Page
- 1
- …
- 148
- 149
- 150
- 151
- 152
- …
- 338
- Next Page »